Saline Contrast Electrical Impedance Tomography Method for Diagnosis of Acute Pulmonary Embolism
ECTPED
A Multicenter Comparative Study of Saline Contrast Electrical Impedance Tomography Method Versus CTPA in the Diagnosis of Acute Pulmonary Embolism
1 other identifier
observational
343
1 country
1
Brief Summary
The goal of this observational study is to compare the consistency of saline contrast Electrical Impedance Tomography(EIT) method and Computed Tomography Pulmonary Angiography (CTPA) in diagnosing acute pulmonary embolism. The main question it aims to answer is: Can bedside saline contrast EIT method be used for the diagnosis of acute pulmonary embolism? The participants will undergo saline contrast EIT and CTPA examinations successively within 24 hours.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Sep 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 14, 2025
CompletedFirst Posted
Study publicly available on registry
September 24, 2025
CompletedStudy Start
First participant enrolled
September 24, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
September 15, 2027
October 2, 2025
September 1, 2025
1.6 years
September 14, 2025
September 28, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
The ability of proportion of dead space ventilation to diagnose PE
The participant undergoes a saline contrast EIT examination, after which the distribution of pulmonary ventilation and perfusion will be obtained, respectively. A V-Q map will be subsequently generated. Using offline EIT data analysis tool, the proportion of lung regions with ventilation but without perfusion is calculated, representing the proportion of dead space ventilation (expressed as a percentage). Area under the receiver operating characteristic curve (AUROC), sensitivity, specificity, Youden's index, accuracy, Kappa statistic, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (PLR) and negative likelihood ratio (NLR) will be used to evaluate the ability of proportion of dead space ventilation to diagnose acute pulmonary embolism (PE).
Within 24 hours before or after the CTPA examination
Secondary Outcomes (3)
The ability of proportion of V/Q matching to diagnose PE
Within 24 hours before or after the CTPA examination
The ability of proportion of shunt to diagnose PE
Within 24 hours before or after the CTPA examination
The ability of other indicators reflecting pulmonary ventilation and perfusion to diagnose PE
Within 24 hours before or after the CTPA examination
Study Arms (1)
Patients clinically suspected with acute PE
This study will enroll adult patients (\>18 years) with clinically suspected or confirmed acute pulmonary embolism (PE) presenting with acute respiratory failure, who either undergo computed tomography pulmonary angiography (CTPA) within 24 hours or are scheduled for CTPA within the next 24 hours. Eligible participants need to have an indwelling central venous catheter (internal jugular or subclavian vein) or a peripheral forearm venous line, with no restrictions on gender.
Interventions
This study will enroll patients with clinically suspected or confirmed acute pulmonary embolism (PE) presenting with acute respiratory failure, who undergo electrical impedance tomography (EIT) with saline contrast within 24 hours before or after computed tomography pulmonary angiography (CTPA). The EIT procedure is performed as follows: 1. Breath-Hold Maneuver: (1)Spontaneous breathing patients: Supine position, instructed to hold expiration for ≥8 seconds. (2)Mechanically ventilated patients: Expiratory hold (\>8 sec) achieved via ventilator; deeper sedation will be applied when feasible to prolong breath-hold. 2. Venous Access: (1)Preferred: Central venous catheter (internal jugular or subclavian vein).(2)Alternative: Peripheral forearm vein (preferably the median cubital vein). 3. Contrast Administration:(1)Central venous route: 10 mL of 10% NaCl.(2)Peripheral venous route: 15 mL of 5% NaHCO₃.
Patients who meet the inclusion criteria will undergo CTPA examination using conventional clinical diagnostic methods.
Eligibility Criteria
Patients with clinically suspected or confirmed acute pulmonary embolism (PE) presenting with acute respiratory failure.
You may qualify if:
- Patients with clinically suspected or confirmed acute pulmonary embolism (PE) presenting with acute respiratory failure;
- Availability of CTPA results within 24 hours or scheduled to undergo CTPA within the next 24 hours;
- Age \>18 years; no gender restrictions;
- Presence of central venous access (internal jugular or subclavian vein) or peripheral forearm venous access;
- Willingness to participate with signed informed consent from either the patient or legal guardian.
You may not qualify if:
- Pregnancy or lactation;
- Relative contraindications to EIT examination (e.g., chest wall wounds at electrode belt placement site, presence of pacemakers);
- Severe hypernatremia (serum sodium \>155 mmol/L);
- Inability to maintain expiratory breath-hold for ≥8 seconds;
- BMI \>50 or severe thoracic deformities;
- Current extracorporeal membrane oxygenation (ECMO) therapy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100730, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 14, 2025
First Posted
September 24, 2025
Study Start
September 24, 2025
Primary Completion (Estimated)
May 1, 2027
Study Completion (Estimated)
September 15, 2027
Last Updated
October 2, 2025
Record last verified: 2025-09
Data Sharing
- IPD Sharing
- Will not share